8.41

1.29% -0.11

Alpha Cognition Inc (ACOG)

Overview News Price History Discussions Forecast

Alpha Cognition Inc stock is traded at $8.41, with a volume of 56,692. It is down -1.29% in the last 24 hours and up +40.40% over the past month. Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Previous Close:

$8.52

Open:

$8.73

24h Volume:

56,692

Relative Volume:

1.27

Market Cap:

$183.12M

Revenue:

$10.83M

Net Income/Loss:

$-25.14M

P/E Ratio:

-6.128

EPS:

-1.3724

Net Cash Flow:

$-30.41M

1W Performance:

+6.59%

1M Performance:

+40.40%

6M Performance:

+28.79%

1Y Performance:

-23.55%

1-Day Range:

$8.40

$8.80

1-Week Range:

$7.50

$8.80

52-Week Range:

$4.50

$11.20

Alpha Cognition Inc Stock (ACOG) Company Profile

Name

Alpha Cognition Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

(858) 344-4375

Address

1452 HUGHES RD., STE. 200, GRAPEVINE

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

ACOG's Discussions on Twitter

Compare ACOG vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACOG Alpha Cognition Inc	8.41	183.12M	10.83M	-25.14M	-30.41M	-1.3724
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-17-26	Initiated	Craig Hallum	Buy
Mar-18-25	Initiated	H.C. Wainwright	Buy

Alpha Cognition Inc Stock (ACOG) Latest News

Jul 11, 2026

Alpha Cognition (ACOG) Stock Fair Value Moves Lower As Analysts Weigh Zunveyl Persistence - Yahoo Finance

Jul 11, 2026

Jul 10, 2026

ACOG Initiates Coverage by Raymond James -- Rating Set to Outper - GuruFocus

Jul 10, 2026

Raymond James initiates Alpha Cognition stock coverage with outperform rating - Investing.com UK

Jul 10, 2026

Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit - Business Wire

Jul 10, 2026

Raymond James initiates Alpha Cognition stock coverage with outperform rating By Investing.com - Investing.com South Africa

Jul 10, 2026

Jul 07, 2026

Price to sales forward of Alpha Cognition Inc. – NASDAQ:ACOG - TradingView

Jul 07, 2026

Jul 06, 2026

ACOGAlpha Cognition Inc Latest SEC Filings - Finviz

Jul 06, 2026

Jul 04, 2026

Enterprise value to revenue forward of Alpha Cognition Inc. – NASDAQ:ACOG - TradingView

Jul 04, 2026

Alpha Cognition | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc. - Moomoo

Jun 29, 2026

Jun 26, 2026

Alpha Cognition Inc Actuals & Estimates (NASDAQ:ACOG) - TradingView

Jun 26, 2026

ACOG Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 23, 2026